Skip to main content
. 2015 Feb 13;9(3):266–275. doi: 10.1093/ecco-jcc/jju026

Table 5.

Infusion reactions during HD IFX therapy.

n = 86 Patients affected Tolerated with premedications, n Discontinued HD IFX, n
n %
Acute infusion reactions 10 11.6% 9 1
 Milda 2 3.5% 2 0
 Moderateb 8 9.3% 7 1
  Severec 0 0.0% 0 0
Delayed infusion reactions 5 5.8% 4 1

HD IFX, high dose infliximab.

aMild: hyperemia, palpitations, diaphoresis, headache, dizziness, nausea.

bModerate: mild hypo/hypertension, chest discomfort, shortness of breath, elevated temperature, palpitations, urticaria.

cSevere: significant hypo/hypertension, elevated temperature with rigors, significant shortness of breath, stridor.